SCHEMBL4602176

SCHEMBL4602176

CCC(CC)NS(=O)(=O)CCCc1ccc(OCCOC)cc1Oc1ncc(C(F)(F)F)cc1Cl

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4600911 0.90 PPARG (0.64) PPARG
SCHEMBL4601718 0.90 PPARG (0.73) PPARG
SCHEMBL4602514 0.86 PPARG (0.79) PPARG
SCHEMBL4601497 0.86 PPARG (0.79) PPARG
SCHEMBL4601947 0.86 PPARG (0.81) PPARG
SCHEMBL4601581 0.85 PPARG (0.83) PPARG
SCHEMBL4529260 0.85 PPARG (0.61) PPARG
SCHEMBL3207108 0.85 PPARG (1.00) PPARG
SCHEMBL4600943 0.85 PPARG (0.83) PPARG
SCHEMBL4600064 0.85 PPARG (0.80) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed